Knopp Biosciences Receives Key Patent Directed to Ion Channel Activators for Brain Disorders
Knopp Biosciences LLC announced it has received the patent entitled “Benzoimidazol-1,2-yl amides as Kv7 channel activators” The patent strengthens the company’s efforts directed to a series of orally available small molecules for treatment of epilepsy, neuropathic pain, and other neurological … Continued